NHRF1_HUMAN - dbPTM
NHRF1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NHRF1_HUMAN
UniProt AC O14745
Protein Name Na(+)/H(+) exchange regulatory cofactor NHE-RF1
Gene Name SLC9A3R1
Organism Homo sapiens (Human).
Sequence Length 358
Subcellular Localization Cytoplasm. Apical cell membrane. Endomembrane system
Peripheral membrane protein. Cell projection, filopodium. Cell projection, ruffle. Cell projection, microvillus. Translocates from the cytoplasm to the apical cell membrane in a PODXL-dependent ma
Protein Description Scaffold protein that connects plasma membrane proteins with members of the ezrin/moesin/radixin family and thereby helps to link them to the actin cytoskeleton and to regulate their surface expression. Necessary for recycling of internalized ADRB2. Was first known to play a role in the regulation of the activity and subcellular location of SLC9A3. Necessary for cAMP-mediated phosphorylation and inhibition of SLC9A3. May enhance Wnt signaling. May participate in HTR4 targeting to microvilli (By similarity). Involved in the regulation of phosphate reabsorption in the renal proximal tubules. Involved in sperm capacitation. May participate in the regulation of the chloride and bicarbonate homeostasis in spermatozoa..
Protein Sequence MSADAAAGAPLPRLCCLEKGPNGYGFHLHGEKGKLGQYIRLVEPGSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETDEQLQKLGVQVREELLRAQEAPGQAEPPAAAEVQGAGNENEPREADKSHPEQRELRPRLCTMKKGPSGYGFNLHSDKSKPGQFIRSVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSDTSEELNSQDSPPKQDSTAPSSTSSSDPILDFNISLAMAKERAHQKRSSKRAPQMDWSKKNELFSNL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MSADAAAGA
------CCHHHHCCC
34.5519413330
2Phosphorylation------MSADAAAGA
------CCHHHHCCC
34.5523401153
15S-nitrosylationGAPLPRLCCLEKGPN
CCCCCEEEEECCCCC
2.3524105792
16S-nitrosylationAPLPRLCCLEKGPNG
CCCCEEEEECCCCCC
6.9624105792
19AcetylationPRLCCLEKGPNGYGF
CEEEEECCCCCCCEE
67.7223749302
32AcetylationGFHLHGEKGKLGQYI
EEEEECCCCCCCEEE
66.9719608861
34AcetylationHLHGEKGKLGQYIRL
EEECCCCCCCEEEEE
61.5925953088
38PhosphorylationEKGKLGQYIRLVEPG
CCCCCCEEEEEECCC
6.0422817900
46PhosphorylationIRLVEPGSPAEKAGL
EEEECCCCHHHHHCC
31.4925159151
50UbiquitinationEPGSPAEKAGLLAGD
CCCCHHHHHCCCCCC
50.2721906983
502-HydroxyisobutyrylationEPGSPAEKAGLLAGD
CCCCHHHHHCCCCCC
50.27-
58MethylationAGLLAGDRLVEVNGE
HCCCCCCEEEEECCC
39.45115484969
69UbiquitinationVNGENVEKETHQQVV
ECCCCCCHHHHHHHH
64.7324816145
69AcetylationVNGENVEKETHQQVV
ECCCCCCHHHHHHHH
64.7325953088
77PhosphorylationETHQQVVSRIRAALN
HHHHHHHHHHHHHHH
24.1222817900
95PhosphorylationLLVVDPETDEQLQKL
EEEECCCCHHHHHHH
50.6622817900
101UbiquitinationETDEQLQKLGVQVRE
CCHHHHHHHCHHHHH
56.6621963094
156PhosphorylationELRPRLCTMKKGPSG
HHHHCEECCCCCCCC
36.30-
158UbiquitinationRPRLCTMKKGPSGYG
HHCEECCCCCCCCCC
36.1023503661
159UbiquitinationPRLCTMKKGPSGYGF
HCEECCCCCCCCCCC
66.2923503661
162PhosphorylationCTMKKGPSGYGFNLH
ECCCCCCCCCCCCCC
54.0025159151
164PhosphorylationMKKGPSGYGFNLHSD
CCCCCCCCCCCCCCC
23.9225307156
170PhosphorylationGYGFNLHSDKSKPGQ
CCCCCCCCCCCCCCC
50.3120873877
172UbiquitinationGFNLHSDKSKPGQFI
CCCCCCCCCCCCCEE
64.4929967540
173PhosphorylationFNLHSDKSKPGQFIR
CCCCCCCCCCCCEEE
49.42-
181PhosphorylationKPGQFIRSVDPDSPA
CCCCEEEECCCCCHH
26.5128258704
186PhosphorylationIRSVDPDSPAEASGL
EEECCCCCHHHHCCC
31.2521815630
191PhosphorylationPDSPAEASGLRAQDR
CCCHHHHCCCCHHCC
29.84-
195UbiquitinationAEASGLRAQDRIVEV
HHHCCCCHHCCEEEE
22.22-
206S-nitrosylationIVEVNGVCMEGKQHG
EEEECCEEECCCCCC
1.8624105792
210AcetylationNGVCMEGKQHGDVVS
CCEEECCCCCCCCEE
26.3026051181
217PhosphorylationKQHGDVVSAIRAGGD
CCCCCCEEEEEECCC
20.1621406692
226PhosphorylationIRAGGDETKLLVVDR
EEECCCCCEEEEEEC
31.5621406692
227UbiquitinationRAGGDETKLLVVDRE
EECCCCCEEEEEECC
37.4624816145
240AcetylationRETDEFFKKCRVIPS
CCHHHHHHHCCCCCC
57.1725953088
2402-HydroxyisobutyrylationRETDEFFKKCRVIPS
CCHHHHHHHCCCCCC
57.17-
241UbiquitinationETDEFFKKCRVIPSQ
CHHHHHHHCCCCCCC
23.3224816145
247PhosphorylationKKCRVIPSQEHLNGP
HHCCCCCCCHHCCCC
36.7624719451
260PhosphorylationGPLPVPFTNGEIQKE
CCCCCCCCCCCCCCC
35.9226657352
269PhosphorylationGEIQKENSREALAEA
CCCCCCCHHHHHHHH
32.3725159151
280O-linked_GlycosylationLAEAALESPRPALVR
HHHHHHHCCCCHHHH
27.36OGP
280PhosphorylationLAEAALESPRPALVR
HHHHHHHCCCCHHHH
27.3619664994
288PhosphorylationPRPALVRSASSDTSE
CCCHHHHCCCCCCHH
25.6429255136
290PhosphorylationPALVRSASSDTSEEL
CHHHHCCCCCCHHHH
29.9629255136
291PhosphorylationALVRSASSDTSEELN
HHHHCCCCCCHHHHH
44.6229255136
293PhosphorylationVRSASSDTSEELNSQ
HHCCCCCCHHHHHCC
39.7322167270
294PhosphorylationRSASSDTSEELNSQD
HCCCCCCHHHHHCCC
33.7819664994
299PhosphorylationDTSEELNSQDSPPKQ
CCHHHHHCCCCCCCC
48.2519664994
302PhosphorylationEELNSQDSPPKQDST
HHHHCCCCCCCCCCC
35.1519664994
308PhosphorylationDSPPKQDSTAPSSTS
CCCCCCCCCCCCCCC
24.7923663014
309PhosphorylationSPPKQDSTAPSSTSS
CCCCCCCCCCCCCCC
51.3723663014
312PhosphorylationKQDSTAPSSTSSSDP
CCCCCCCCCCCCCCC
43.7323663014
313PhosphorylationQDSTAPSSTSSSDPI
CCCCCCCCCCCCCCC
31.1123663014
314PhosphorylationDSTAPSSTSSSDPIL
CCCCCCCCCCCCCCC
36.6426657352
315PhosphorylationSTAPSSTSSSDPILD
CCCCCCCCCCCCCCC
29.7723663014
316PhosphorylationTAPSSTSSSDPILDF
CCCCCCCCCCCCCCH
38.5623663014
317PhosphorylationAPSSTSSSDPILDFN
CCCCCCCCCCCCCHH
47.3630278072
326PhosphorylationPILDFNISLAMAKER
CCCCHHHHHHHHHHH
15.9220068231
339PhosphorylationERAHQKRSSKRAPQM
HHHHHHHHCCCCCCC
47.4417613530
340PhosphorylationRAHQKRSSKRAPQMD
HHHHHHHCCCCCCCC
30.1417613530
349PhosphorylationRAPQMDWSKKNELFS
CCCCCCHHHHHHHHH
29.5026074081
350UbiquitinationAPQMDWSKKNELFSN
CCCCCHHHHHHHHHC
56.2029967540
351UbiquitinationPQMDWSKKNELFSNL
CCCCHHHHHHHHHCC
50.57-
356PhosphorylationSKKNELFSNL-----
HHHHHHHHCC-----
50.2628555341

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
77SPhosphorylationKinasePRKCAP17252
GPS
156TPhosphorylationKinaseAKT1P31749
PSP
156TPhosphorylationKinaseRPS6KA1Q15418
GPS
162SPhosphorylationKinasePRKCAP17252
GPS
280SPhosphorylationKinaseCDK1P06493
PSP
290SPhosphorylationKinaseGRK6P43250
PhosphoELM
302SPhosphorylationKinaseCDK1P06493
PSP
339SPhosphorylationKinasePRKCAP17252
GPS
340SPhosphorylationKinasePRKCAP17252
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NHRF1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NHRF1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
OPRK_HUMANOPRK1physical
15070904
NHRF1_HUMANSLC9A3R1physical
15070904
SL9A3_HUMANSLC9A3physical
14580213
CFTR_HUMANCFTRphysical
9613608
TRPC5_MOUSETrpc5physical
10980202
TRPC4_MOUSETrpc4physical
10980202
PLCB1_HUMANPLCB1physical
10980202
PLCB1_BOVINPLCB1physical
10980202
YAP1_HUMANYAP1physical
10562288
YES_HUMANYES1physical
10562288
ADRB2_HUMANADRB2physical
11882663
S4A8_HUMANSLC4A8physical
12444018
TB10A_HUMANTBC1D10Aphysical
11285285
CFTR_HUMANCFTRphysical
10852925
CLCN3_HUMANCLCN3physical
12471024
CFTR_HUMANCFTRphysical
12471024
PGFRA_HUMANPDGFRAphysical
11046132
PGFRB_HUMANPDGFRBphysical
11046132
NHRF1_HUMANSLC9A3R1physical
11046132
PHAG1_HUMANPAG1physical
11684085
EZRI_HUMANEZRphysical
9314537
CFTR_HUMANCFTRphysical
9677412
CFTR_HUMANCFTRphysical
12403779
ADRB2_HUMANADRB2physical
11526121
RNT2_HUMANRNASET2physical
22939629
TACC1_HUMANTACC1physical
22939629
UCRI_HUMANUQCRFS1physical
22939629
PCYOX_HUMANPCYOX1physical
22939629
RS3_HUMANRPS3physical
22939629
PPME1_HUMANPPME1physical
22939629
PALM2_HUMANPALM2physical
22939629
PTEN_HUMANPTENphysical
23118026
EPHB1_HUMANEPHB1physical
23118026
MRP4_HUMANABCC4physical
18045536
ZN468_HUMANZNF468physical
21988832
GNA11_HUMANGNA11physical
12193606
CAN1_HUMANCAPN1physical
22863883
KCRB_HUMANCKBphysical
22863883
G6PD_HUMANG6PDphysical
22863883
LDHB_HUMANLDHBphysical
22863883
SIAS_HUMANNANSphysical
22863883
RL23_HUMANRPL23physical
22863883
TGM2_HUMANTGM2physical
22863883
UBFD1_HUMANUBFD1physical
22863883
1433T_HUMANYWHAQphysical
22863883
1433Z_HUMANYWHAZphysical
22863883
MRP4_HUMANABCC4physical
18559527
SKP2_HUMANSKP2physical
25492869
AKT1_HUMANAKT1physical
25492869
IREB2_HUMANIREB2physical
26344197
S4A7_HUMANSLC4A7physical
12403779
KPCA_HUMANPRKCAphysical
12954600
PHLP1_HUMANPHLPP1physical
21804599
PHLP2_HUMANPHLPP2physical
21804599
MRP2_HUMANABCC2physical
25163515
MK01_HUMANMAPK1physical
20736378
CADH2_HUMANCDH2physical
20736378

Drug and Disease Associations
Kegg Disease
H00888 Nephrolithiasis/osteoporosis, hypophosphatemic
OMIM Disease
612287Nephrolithiasis/osteoporosis, hypophosphatemic, 2 (NPHLOP2)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NHRF1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46 AND SER-280, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280, AND MASSSPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280; SER-290; SER-291AND THR-293, AND MASS SPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280, AND MASSSPECTROMETRY.

TOP